Tamar Tsertsvadze
Tbilisi, TB, Georgia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The effect of IL-4 on CD180 expression and signalling in Chronic lymphocytic leukaemia (CLL).
Journal: Leukemia research
Published: September 05, 2025
Expression and signaling patterns of CD180/MD-1 and CD150 in Chronic Lymphocytic Leukaemia (CLL) cells.
Journal: Leukemia research
Published: August 27, 2025
Characteristics and Antitumor Activity of Doxorubicin-Loaded Multifunctional Iron Oxide Nanoparticles in MEC1 and RM1 Cell Lines.
Journal: Journal of functional biomaterials
Published: September 26, 2024
MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL.
Journal: Leukemia research
Published: February 13, 2024
Synthesis, Characterization, and In Vitro Cytotoxicity Evaluation of Doxorubicin-Loaded Magnetite Nanoparticles on Triple-Negative Breast Cancer Cell Lines.
Journal: Pharmaceutics
Published: May 05, 2023
The role of CD180 in hematological malignancies and inflammatory disorders.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 28, 2023
Galactose specific lectins from prostate tissue with different pathologies: biochemical and cellular studies.
Journal: Molecular biology reports
Published: August 08, 2021
Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 30, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026